Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a large and very diverse group of neoplasms. Clinical presentation of NETs depends on the site of the primary tumor and whether the tumor is functioning (i.e., secreting peptides or neuroamines that produce symptoms). The diagnosis of GEP-N...

Full description

Bibliographic Details
Main Authors: Beata Kos-Kudła, Jarosław Ćwikła, Marek Ruchała, Alicja Hubalewska-Dydejczyk, Barbara Jarzab, Jolanta Krajewska, Grzegorz Kamiński
Format: Article
Language:English
Published: Termedia Publishing House 2017-06-01
Series:Contemporary Oncology
Subjects:
gastroenteropancreatic neuroendocrine tumors
GEP-NETs
somatostatin analogue
lanreotide
CLARINET
Online Access:https://www.termedia.pl/Current-treatment-options-for-gastroenteropancreatic-neuroendocrine-tumors-with-a-focus-on-the-role-of-lanreotide,3,30171,1,1.html

Internet

https://www.termedia.pl/Current-treatment-options-for-gastroenteropancreatic-neuroendocrine-tumors-with-a-focus-on-the-role-of-lanreotide,3,30171,1,1.html

Similar Items